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Treatment recommendations for invasive aspergillosis.

  Recommendation   Drug                                  Dosing                                                                                                                                                                Comments
  ---------------- ------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------
  Primary          Voriconazole                          6 mg/kg IV every 12 h times two then 4 mg/kg IV every 12 h                                                                                                            Oral therapy at mg/kg dosing or 200--300 mg every 12 h; TDM required
  Alternatives     Lipsosomal amphotericin B (L-AMB)     3--5 mg/kg/day IV                                                                                                                                                     
                   Isavuconazole                         200 mg every 8 h IV or PO times six then 200 mg daily IV or PO                                                                                                        Need for TDM remains undefined
                   Voriconazole plus Anidulafungin       Vorizonazole as above plus Anidulafungin 200 mg IV daily times one then 100 mg IV daily                                                                               Combination therapy considered in severe disease and with hematologic malignancy
                   Amphotericin B Lipid Complex (ABLC)   5 mg/kg/day IV                                                                                                                                                        
  Secondary        Caspofungin                           70 mg IV daily times one then 50 mg IV daily                                                                                                                          Monotherapy as salvage
                   Posaconazole                          Oral suspension: 200 mg PO every 8 h, Tablet: 300 mg PO every 12 h times two then 300 mg PO daily, Intravenous: 300 mg IV every 12 h times two then 300 mg IV daily   Caution in use of tablet formulation with acid suppression; TDM required
                   Itraconazole                          200 mg PO every 12 h                                                                                                                                                  TDM required
